galenIQ™ — the smart excipient
The isomalt based excipient range galenIQ™ is a multifunctional filler and binder. Manufactured in different grades, it is used for various direct oral applications and the corresponding processing technologies.
galenIQ the smart excipient
BENEO-Palatinit’s excipient galenIQ (Isomalt Ph Eur, BP, USP-NF, approved also in Japan (PMDA) and China (Import Drug License)) is a range of multifunctional fillers and binders.
galenIQ includes grades for powder blends and compression applications as well special ground grades for processing technologies such as wet granulation, roller compaction and fluid bed agglomeration. Its broad range of different particle modifications and solubilities provides the best solution for various direct oral applications like tablets, capsule and sachet fillings.
All grades show the multifunctional characteristic such as excellent compactibility, flowability and very low hygroscopicity. galenIQ has a specific morphology preventing segregation and thus ensuring content uniformity, which makes it suitable for very high dose as well as low dose applications. Also, it is physically and chemically extremely stable. Derived from beet sugar it has a sweet sugarlike taste. This sweet, well balanced taste is a decisive advantage for the formulation of direct oral applications, even in combination with active ingredients of unpleasant taste profiles.
BENEO-Palatinit, part of the Südzucker Group, is a member of the International Pharmaceutical Excipients Council (IPEC) and produces galenIQ under GMP conditions for pharmaceutical excipients.
www.galenIQ.comgalenIQ@beneo.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Adding SYLOID® Mesoporous Silica to Improve Run Time and Yield for Micronization Processes
May 9th 2025A must-read for anyone in the industry looking to enhance their micronization processes. Discover how adding low percentages of SYLOID® mesoporous silica can significantly improve the run time and yield of jet milling processes for hard-to-process Active Pharmaceutical Ingredients (APIs). Imagine achieving a more consistent feed rate and a homogenous final product simply by pre-blending SYLOID® mesoporous silica with your APIs. Grace & Microsize conducted experiments that reveal substantial improvements in both run time and yield, making this paper an essential guide for professionals aiming to optimize their manufacturing processes and boost efficiency and feed rate consistency.
